The peril of biotech investing:
ALS drug maker's phase 3 confirmation trial failed.
https://finance.yahoo.com/m/b15fb91a-1e90-3259-844e-cfdb256344de/amylyx-stock-wipes-out-nearly.html
ALS drug maker's phase 3 confirmation trial failed.
https://finance.yahoo.com/m/b15fb91a-1e90-3259-844e-cfdb256344de/amylyx-stock-wipes-out-nearly.html

, and you passed with flying color.